Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysis.
Bousema JE, van Dorp M, Hoeijmakers F, Huijbregts IA, Barlo NP, Bootsma GP, van Boven WP, Claessens NJM, Dingemans AC, Hanselaar WE, Kortekaas RTJ, Lardenoije JHP, Maessen JG, Schreurs WH, Vissers Y, Youssef-El Soud M, Dijkgraaf MGW, Annema J, van den Broek FJC. Bousema JE, et al. Among authors: dingemans ac. Lung Cancer. 2019 Aug;134:52-58. doi: 10.1016/j.lungcan.2019.05.031. Epub 2019 May 30. Lung Cancer. 2019. PMID: 31319995
Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM, Langen RC, Minnaard R, Kelders MC, Snepvangers FJ, Hesselink MK, Dingemans AC, Schols AM. Op den Kamp CM, et al. Among authors: dingemans ac. Lung Cancer. 2012 Apr;76(1):112-7. doi: 10.1016/j.lungcan.2011.09.012. Epub 2011 Oct 20. Lung Cancer. 2012. PMID: 22018880 Free article.
Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.
Driessen EJ, Bootsma GP, Hendriks LE, van den Berkmortel FW, Bogaarts BA, van Loon JG, Dingemans AC, Janssen-Heijnen ML. Driessen EJ, et al. Among authors: dingemans ac. Radiother Oncol. 2016 Oct;121(1):26-31. doi: 10.1016/j.radonc.2016.07.025. Epub 2016 Aug 10. Radiother Oncol. 2016. PMID: 27522577
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
Hendriks LEL, Brouns -JWM, Amini M, Uyterlinde W, Wijsman R, Bussink J, Biesma B, Oei SB, Stigt JA, Bootsma GP, Belderbos JSA, De Ruysscher DKM, Van den Heuvel MM, Dingemans AC. Hendriks LEL, et al. Among authors: dingemans ac. Lung Cancer. 2016 Nov;101:68-75. doi: 10.1016/j.lungcan.2016.09.008. Epub 2016 Sep 9. Lung Cancer. 2016. PMID: 27794410 Free article.
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3).
Forster M, Hackshaw A, De Pas T, Cobo M, Garrido P, Summers Y, Dingemans AC, Flynn M, Schnell D, von Wangenheim U, Loembé AB, Kaiser R, Lee SM. Forster M, et al. Among authors: dingemans ac. Lung Cancer. 2018 Jun;120:27-33. doi: 10.1016/j.lungcan.2018.03.007. Epub 2018 Mar 9. Lung Cancer. 2018. PMID: 29748012 Free article. Clinical Trial.
MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial.
Bousema JE, Dijkgraaf MGW, Papen-Botterhuis NE, Schreurs HW, Maessen JG, van der Heijden EH, Steup WH, Braun J, Noyez VJJM, Hoeijmakers F, Beck N, van Dorp M, Claessens NJM, Hiddinga BI, Daniels JMA, Heineman DJ, Zandbergen HR, Verhagen AFTM, van Schil PE, Annema JT, van den Broek FJC; MEDIASTrial study group. Bousema JE, et al. BMC Surg. 2018 May 18;18(1):27. doi: 10.1186/s12893-018-0359-6. BMC Surg. 2018. PMID: 29776444 Free PMC article. Clinical Trial.
195 results